NeuroBo Pharma (NRBO) - Kapitalizatsiyaning foydaga nisbati

NeuroBo Pharmaceuticals Inc - NRBO emitenti grafik logotipi

NeuroBo Pharmaceuticals operatsion xatarlarni minimallashtirish uchun klinik sinovlarni tashqi sertifikatlangan laboratoriyalarga autsorsing qilishga tayanadi. Neyrofarmatsevtika vositalari va metabolik buzilishlar uchun davolash usullarini ishlab chiqish Koreyaning yirik ishtirokchilari bilan strategik sheriklikka asoslangan. Biznesning ekologik yo'nalishi dori vositalari sintezida nol chiqindi texnologiyasini joriy etishni nazarda tutadi. Narx ko'rsatkichi (separate_pe) -0.90 qiymatini qayd etdi, bu esa kompaniyaning joriy bozor qiymatini aks ettiradi.

neurobopharma.com (NRBO): Narxning foydaga nisbati 04.07.2022dan 07.12.2024gacha

NeuroBo Pharmaceuticals (NRBO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:NRBO (NeuroBo)
NeuroBo Pharma original mahsuloti

P/E koeffitsiyenti bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni ifodalab, bir dollar foydaning tannarxini belgilaydi. NeuroBo Pharmaceuticals (NRBO) uchun ushbu ko'rsatkich klinik sinovlarning muvaffaqiyatsizligi xatarlariga qarshi spekulyativ kutishlarni aks ettiradi. P/E qoplash ko'rsatkichini tahlil qilish orqali investor semizlik terapiyasi bo'yicha kelgusidagi muvaffaqiyatlar uchun to'langan premiumning miqdorini aniqlashi mumkin. Yuqori qiymatlar aksiya narxi tashqi moliyalashtirishga bog'liqligini anglatadi, bu esa aktivning fundamental barqarorligini shubha ostiga qo'yadi.

Raqobatdosh kompaniyalar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea|Narx-foyda multiplikatori CRGT (Cortigent)|Narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Narx-foyda koeffitsiyenti|ELYM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Narxning foydaga nisbati|Marinus - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NKGen Biotech Inc|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori